Facilitated by
- Sabra S. Custer, DNP, MS, FNP-BC, AAHIVS
Associate Professor
College of Nursing
University of South Carolina - Stewart Roberts
Peer Adherence Coach, Tandem Health
May 29, 2024
Presentation
Slides
- Summarize the pharmacologic action and effectiveness of long-acting injectable (LAI) cabotegravir/rilpivirine (CAB/RPV) for HIV treatment
- List at least three important patient criteria to consider when assessing appropriateness of HIV treatment with LAI CAB/RPV
- Explain the administration process, dosing schedule, and monitoring schedule for LAI CAB/RPV
- List positive and negative patient experiences with using LAI CAB/RPV for HIV treatment
Other Trainings
- Webinar: Let’s Talk About Sex – Getting Comfortable Asking Tough Questions
- Webinar: ART Part 2 – Modifying Antiretroviral Therapy
- Webinar: ART Part 1 – Introduction to Antiretroviral Therapy
- Webinar: Linkage Case Management and Post-hospitalization Outcomes in People with HIV
- Webinar: Basic Topics in HIV Psychiatry
